![]() |
市場調查報告書
商品編碼
1954619
磨牙症治療市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2026-2034 年)Sleeping Bruxism Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球磨牙症治療市場規模為 4.4801 億美元,預計 2026 年將成長至 4.7735 億美元,到 2034 年將達到 8.258 億美元。這意味著在預測期內,複合年增長率 (CAGR) 為 7.09%。北美地區在 2025 年將佔市場領先地位,市場佔有率達 36.08%(相當於 1.6165 億美元),這主要得益於成人磨牙症的高發生率、廣泛的認知以及完善的牙科專業人員網絡。
睡眠磨牙症是一種睡眠期間不自主地咬緊或磨牙的疾病,可導致頭痛、下顎疼痛和牙齒磨損。焦慮、壓力、睡眠障礙和阻塞性睡眠呼吸中止症等因素導致磨牙症風險增加,推動了市場成長。醫院、診所和線上藥局提供的治療方案的擴展也促進了市場成長。
市場動態
成長因素
睡眠磨牙症的盛行率在全球範圍內不斷上升。朱拉隆功大學2023年3月的一項研究表明,約49.7%的阻塞性睡眠呼吸中止症患者同時患有睡眠磨牙症。公眾意識的提高、對牙套和牙夾板等非侵入性治療需求的增長以及診斷技術的進步,正在推動磨牙症治療方案在全球範圍內的普及。
抑制因子
儘管磨牙症盛行率很高,但由於報告不足、認知度低以及缺乏普遍認可的治療方法,實際治療率仍然有限。例如,2020 年土耳其的一項研究報告顯示,只有 3.8% 的家長為孩子尋求磨牙症治療,凸顯了盛行率與治療利用率之間的差距,而這正是限制市場成長的因素。
機會
具有生物回饋功能的智慧牙套正在成為重要的成長機會。這些設備可以監測下顎運動,並提供即時回饋,幫助患者減少磨牙的頻率。根據克利夫蘭診所2023年10月的報告,Prevent Biometrics公司的智慧牙套能夠捕捉下顎運動,並透過無線方式傳輸數據,從而為預防性治療提供精準的測量數據。
市場趨勢
客製化和3D列印技術的進步正在改變磨牙症的治療方式。 3D列印技術能夠精確地數位化製造牙套,從而提高舒適度、貼合度和耐用性。整合感測器後,智慧牙套可以監測下顎活動並提供即時回饋,因此越來越受到成人、運動員和重度磨牙症患者的青睞。
市場挑戰
行為療法、肉毒桿菌注射和肌肉鬆弛劑等替代治療方案的日益普及,正在降低人們對基於器械的治療的需求。新器械的監管壁壘可能會進一步延遲其市場准入,並限制其普及。根據美國國家生物技術資訊中心 (NCBI) 2023 年 7 月的報告,肉毒桿菌注射對常規治療無效的患者有效,這凸顯了其與傳統護齒器解決方案的競爭。
依產品類型:市場細分為護齒器、牙套和其他產品。預計到 2026 年,護齒器將佔市場主導地位,市佔率達 51.79%。 這主要歸功於護齒器作為市售產品易於取得、價格實惠以及可客製化設計。例如,Quip 公司於 2023 年 11 月推出了客製化 Quip Night Guard,將其專業級解決方案拓展至消費者市場。
依患者類型:成年人將主導市場,預計到 2026 年將佔 76.15% 的市場佔有率。這主要是由於顳顎關節障礙 (TMD)、頭痛和牙齒裂縫在成年人群中較為常見。兒科細分市場預計將以 6.4% 的複合年增長率成長。
依最終用戶劃分:牙科診所在 2025 年佔市場主導地位,預計到 2026 年將保持 41.59% 的市場佔有率。這是因為大多數客製化設備都由牙醫開立處方並進行安裝。隨著非處方藥和智慧型設備的普及,家庭護理領域預計將以 6.8% 的複合年增長率成長。
The global sleeping bruxism treatment market was valued at USD 448.01 million in 2025 and is projected to grow to USD 477.35 million in 2026, reaching USD 825.8 million by 2034, representing a CAGR of 7.09% during the forecast period. North America dominated the market in 2025 with a 36.08% share, equivalent to USD 161.65 million, driven by high adult prevalence rates, widespread awareness, and a dense network of dental professionals.
Sleep bruxism is a disorder characterized by involuntary teeth clenching or grinding during sleep, which can cause headaches, jaw pain, and dental wear. The market growth is driven by rising anxiety, stress, sleep disorders, and obstructive sleep apnea, which increase bruxism risk. The expanding availability of treatment options through hospitals, clinics, and online pharmacies also contributes to market expansion.
Market Dynamics
Drivers
The prevalence of sleep bruxism is increasing globally. Studies, such as one from Chulalongkorn University in March 2023, indicate that approximately 49.7% of adults with obstructive sleep apnea exhibit sleep bruxism. Growing public awareness, rising demand for non-invasive treatments like mouth guards and splints, and improved diagnostic technologies are boosting the adoption of bruxism treatment solutions worldwide.
Restraints
Despite high prevalence, actual treatment adoption remains limited due to underreporting, low awareness, and lack of universally accepted therapeutic options. For example, a 2020 study in Turkey reported that only 3.8% of parents sought treatment for their children's bruxism, highlighting the gap between prevalence and treatment usage, which is restricting market growth.
Opportunities
Smart mouth guards with biofeedback features are emerging as a major growth opportunity. These devices monitor jaw activity, provide real-time feedback, and train patients to reduce grinding episodes. According to the Cleveland Clinic in October 2023, Prevent Biometrics' Intelligent Mouthguard captures jaw movements and transmits data wirelessly, providing precise measurements for preventive therapy.
Market Trends
Advances in custom-fit and 3D printing technologies are transforming bruxism treatment. 3D printing allows for precise digital fabrication of mouth guards, enhancing comfort, fit, and durability. Integration with sensors enables smart mouth guards that monitor jaw activity while offering real-time feedback, increasing adoption among adults, athletes, and patients with severe bruxism.
Market Challenges
Alternative treatment options, including behavioral therapies, Botox injections, and muscle relaxants, are reducing demand for device-based treatments. Regulatory hurdles for new devices can further delay market entry and limit adoption. According to NCBI (July 2023), Botulinum toxin injections are effective for patients unresponsive to conventional therapies, highlighting competition with traditional mouth guard solutions.
By Product Type: The market is divided into mouth guards, splints, and others. The mouth guards segment led in 2026 with a 51.79% share, due to OTC availability, affordability, and custom-fitted designs. For example, in November 2023, Quip launched custom-fit Quip Night Guards, expanding professional-grade solutions to consumers.
By Patient Type: Adults dominate the market, holding 76.15% share in 2026, due to higher prevalence of temporomandibular disorders (TMD), headaches, and cracked teeth. The pediatric segment is projected to grow at a CAGR of 6.4%.
By End-User: Dental clinics dominated in 2025, maintaining 41.59% share in 2026, as most custom devices are prescribed and fitted by dentists. Homecare is projected to grow at a CAGR of 6.8% as OTC and smart devices gain traction.
Competitive Landscape
The market is moderately consolidated with key players including SomnoMed, Procter & Gamble (Plackers), Dentsply Sirona, Smile Brilliant, Ivoclar Vivadent, Henry Schein, Quip, Sunstar Group, and ResMed. Strategic initiatives focus on customized devices, innovative materials, digital fabrication, partnerships with dental providers, and online channel expansion.
Recent Developments:
Conclusion
The global sleeping bruxism treatment market, valued at USD 448.01 million in 2025, is projected to grow to USD 477.35 million in 2026 and USD 825.8 million by 2034, at a CAGR of 7.09%. Market growth is supported by rising prevalence of bruxism, increasing awareness, technological advancements in smart and 3D-printed devices, and expanding dental infrastructure. While limited treatment adoption and alternative therapies pose challenges, innovations in personalized solutions and the growing adult patient population are expected to sustain market expansion through 2034.
Segmentation By Product Type, Patient Type, End-user, and Region
By Product Type * Mouth Guards
By Patient Type * Adults
By End-user * Hospitals
By Region * North America (By Product Type, Patient Type, End-user, and Country)